NCT06164704Phase 2Completed

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps

Study sponsor: Upstream Bio Inc. · UPB

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-07-07Actual
Enrollment · participants81Actual
Source updated2026-09-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview